FDA OKs Chromium in Chicken Feed for Better Eggs?
Published Date: 10/14/2026
Rule
Summary
The FDA just gave the green light to use chromium propionate in feed for laying hens and breeder chickens, making their food safer and more nutritious. This change, effective October 14, 2026, mainly affects poultry farmers and feed producers. If anyone wants to object or request a hearing, they have until November 13, 2026, to speak up—no extra costs or fees involved!
Analyzed Economic Effects
3 provisions identified: 2 benefits, 1 costs, 0 mixed.
Chromium propionate approved for poultry feed
The FDA amended 21 CFR 573.304 to allow chromium propionate as a source of chromium in complete feed for broiler chickens, laying hens, breeder chickens, and growing turkeys. This change is effective October 14, 2026.
Strict chromium limit set at 0.2 ppm
The rule sets maximum chromium levels in complete feed at 0.2 milligrams of chromium per kilogram of feed (0.2 parts per million). It also states that chromium from all sources of supplemental chromium cannot exceed 0.2 parts per million of the complete feed.
Deadline to object or request a hearing: Nov 13, 2026
If you will be adversely affected by one or more provisions of this regulation, you may file electronic or written objections and requests for a hearing. Objections and hearing requests must be submitted by November 13, 2026, and may be filed via https://www.regulations.gov or by mail to the Dockets Management Staff.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
Previous / Next Documents
Previous: 2026-20974, Amendment of Boundaries for Restricted Areas R-5301, R-5302B, and R-5302C; NC
The FAA fixed tiny boundary glitches between three restricted airspaces in North Carolina—R-5301, R-5302B, and R-5302C—so there are no gaps or overlaps anymore. This won’t change the size, height, or when these areas are active, just the exact lines on the map. Pilots and airspace users should note the new boundaries take effect December 24, 2026, with no extra costs involved.
Next: 2026-20982, Extending the Reporting Deadline Under the Greenhouse Gas Reporting Rule for Reporting Year 2025 to March 10, 2027
The EPA is giving companies more time to report their 2025 greenhouse gas data by extending the deadline from October 30, 2026, to March 10, 2027. This change only affects the deadline—no other rules are changing. If you’re involved in reporting emissions, this extra time helps you avoid rushing and ensures accurate data without any new costs.